A. Pischedda
University of Sassari
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by A. Pischedda.
Urologia Internationalis | 2005
A. Pischedda; F. Pirozzi Farina; Massimo Madonia; S. Cimino; G. Morgia
Introduction: Bladder outflow obstruction may cause obstructive or irritative symptoms. The diagnosis of female functional bladder neck obstruction requires a pressure/flow study and electromyography performed by videourodynamics. The treatment includes self-catheterization or bladder neck incision. We administered tamsulosin, an α1A/α1D-selective adrenergic antagonist, in women with functional bladder neck obstruction to evaluate its potential therapeutic effects. Patients andMethods: A group of 18 women affected by functional bladder neck obstruction was selected. The diagnosis was made by means of a pressure/flow study combined with electromyography and a fluoroscopic test. The diagnostic criteria were: high detrusor pressure with reduced maximum flow, silent electromyography activity, and bladder neck nonfunnelling during the fluoroscopic test. Tamsulosin 0.4 mg once daily was administered for at least 30 days. Patients with a postvoid residual urine volume ≧100 ml performed intermittent self-catheterization. Patients with a postvoid residual urine volume <100 ml performed self-catheterization every 7 days. After 30 days of therapy, all patients underwent a new pressure/flow study and a micturition fluoroscopic test. Results: 10 (56%) out of 18 treated patients showed a statistically significant improvement in symptoms, maximum flow, and postvoid residual urine volume (p < 0.01). Conclusion: The use of α1-blockers may be an initial treatment option for female functional bladder neck obstruction, as this therapeutic option proved to be effective in more than 50% of our patients suffering from this voiding dysfunction.
Archivio Italiano di Urologia e Andrologia | 2016
Furio Pirozzi Farina; A. Pischedda
Treatment-induced sexual dysfunctions (SD) are a recurrent and controversial topic in recent literature on the adverse events related to the use of 5-alpha-reductase inhibitors (5ARIs) (1, 2). In order to deal adequately with the various aspects of this topic, it is necessary to first cover some of the steps that allow a better definition and understanding of the subject.
Archivio Italiano di Urologia e Andrologia | 2013
A. Pischedda; Ferdinando Fusco; Andrea Curreli; Giovanni Grimaldi; Furio Pirozzi Farina
UROGYNAECOLOGIA INTERNATIONAL JOURNAL | 2010
A. Pischedda; F. Pirozzi Farina; A. Mattana; M. Deriu; Giuliana Solinas; E. Bercovich
XXV Congresso Nazionale Soc. It. di Andrologia (SIA) | 2009
A. Pischedda; A. Curreli; F Pirozzi Farina
Congresso del Centenario della Soc. Italiana di Urologia (SIU) | 2008
A. Curreli; A. Pischedda; F Pirozzi Farina
Urology | 2006
Massimo Madonia; Gerolamo Barabino; L. Cau; M. Catania; F. Pirozzi Farina; A. Pischedda; M. Dedola; G. Ghisu; G. Canalis; G. Morgia
The Journal of Urology | 2006
Massimo Madonia; A. Pischedda; Furio Pirozzi Farina; Giuseppe Morgia
Studia Informatica Universalis | 2005
G Romano; D. Brotza; S Poddighe; A. Pischedda; Massimo Madonia; F Pirozzi Farina; M Morgia
European Urology Supplements | 2005
Giuseppe Morgia; Massimo Madonia; A. Pischedda; Sebastiano Cimino; D. Brotza; M. Catania; F. Pirozzi Farina